Research indicates that while the most severe effects of SARS-CoV-2 were observed in patients with acute COVID-19, individuals who experienced milder cases and were not hospitalized also reported symptoms of memory loss and attention deficits lasting over 18 months post-infection.
Memory loss and attention deficit are common complaints among severe COVID-19 survivors. However, these and other cognitive impairments have also been observed in patients with mild cases more than 18 months after infection, according to a study by researchers at the University of São Paulo (USP) in Brazil.
An article on the study is published in the journal BMC Psychology. The findings highlight the need for more comprehensive rehabilitation to address the enduring cognitive impacts of long COVID, the authors write.
Data collected from 302 volunteers pointed to cognitive impairment in 11.7% of mild patients, 39.2% of moderate patients, and 48.9% of severe patients.
“Although the damage done by the disease in terms of memory loss, attention deficit, and slow processing increases in proportion to its severity, the same problems affect a far from a negligible number of people – around 100 in our study – who had mild or moderate COVID,” said Antônio de Pádua Serafim, first author of the article and a professor at the Institute of Psychology (IP-USP).
The results of the study, which was funded by FAPESP, evidence the potential impact of neuroinflammation due to infection by SARS-CoV-2.
“Memory loss and attention deficit are known to be associated with post-intensive care syndrome due to intubation under deep anesthesia. Some of the data analyzed in the study, however, was from patients who didn’t require intensive care or didn’t even have sufficient symptoms to be hospitalized and nevertheless exhibited memory loss and attention deficit. The findings therefore opened our eyes to the question of neuroinflammation due to COVID-19,” Serafim said.
Memory and attention are important cognitive functions that affect people’s day-to-day lives. Reflecting this, participants in the study with poor memory and attention test scores reported difficulties with recalling words or performing routine activities, such as forgetting pots on the stove or failing to pick children up from school.
“Hierarchically speaking, attention is the primary function in all mental activity, and this explains why attention deficit has such as huge impact on people’s daily lives. High-quality attention is required to think and act in various ways at the same time. Impairment of attention in turn affects memory. In some cases, attentional activity is so dispersed that each new stimulus [or impending activity] dissolves, so that the person can’t remember what they were doing. This also affects processing activity, which involves rapid decision-making based on information,” he said.
Cognitive rehabilitation
According to Serafim, all the evidence has shown for some time that SARS-CoV-2 can affect the central nervous system as well as the lungs, kidneys, heart, and muscles, but the extent of the damage it may cause is poorly understood. “We don’t know if cognitive impairment due to COVID-19 is permanent, and we’re currently evaluating ways to intervene in this process,” he said.
In partnership with other researchers at USP, Serafim is developing programs to try to mitigate the cognitive losses caused by COVID-19. The aim is to find out whether techniques such as neurostimulation and neurofeedback can attenuate or reserve memory loss and attention deficit.
“Both are non-invasive techniques that aim to improve brain functions by means of neuromodulation, which can stimulate the connections among neurons in the brain [synapses]. We have only case studies so far. For example, in the case of a physician who was in the intensive care unit for 34 days, we conducted a neurofeedback protocol often used to study patients with attention deficit disorder, and he made a good recovery. But that was an isolated case,” he said.
“Based on the knowledge we’ve acquired so far regarding cognitive stimulation and rehabilitation techniques, I believe it may be possible to obtain an improvement in neural connectivity by means of brain training to stimulate overall cognitive ability. The severe phase of the pandemic is over, but the sequelae persist. So it’s not a closed case. Many people were infected, and many have sequelae of this kind. However, we don’t have an effective program to intervene not only in the emotional aspects but also in the cognitive difficulties resulting from COVID-19.”
Reference: “Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations” by Antonio de Pádua Serafim, Fabiana Saffi, Amanda Rafaella A. Soares, Alessandra Mara Morita, Mariana Medeiros Assed, Sandro de Toledo, Cristiana C. A. Rocca and Ricardo S. S. Durães, 26 April 2024, BMC Psychology.
DOI: 10.1186/s40359-024-01740-7
The study was funded by the São Paulo Research Foundation.

News
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]